Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Travelers Companies Inc. Common Stock (TRV) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

The Travelers Companies Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

The Travelers Companies Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? The Travelers Companies Inc. Common Stock trades at $377.77 (market cap $77.86B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: The Travelers Companies Inc. Common Stock is far larger — about 43.3× Vir Biotechnology Inc. Common Stock's market cap, and The Travelers Companies Inc. Common Stock pays a 1.34% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Travelers Companies Inc. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TRVVIR
Market Cap
$77.86B$1.80B
Volume
986,7761,782,836
Sector
FinancialsHealth
52-Week High
$397.22$11.78
52-Week Low
$261.57$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$86.44B$1.36B
Dividend Yield
1.34%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Travelers Companies Inc. Common Stock

TRV trades at $373.28, up 0.43% with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with a P/E of 10.03 and ROE of 26.32%, while consistently beating earnings estimates in recent quarters. Recent news highlights Travelers' earnings momentum ahead of Q3 results.

The outlook remains positive given valuation attractiveness and earnings beat history, though risks include competitive pressures and potential earnings volatility. Analyst consensus is mixed with 25% buy ratings but a $353.80 price target below current levels, suggesting cautious optimism.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TRV

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About The Travelers Companies Inc. Common Stock

The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.

Read more on TRV →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →